全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量
210

相关文章

更多...
-  2019 

Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass Grafting

DOI: 10.14740/cr842

Keywords: Clopidogrel, CABG, Bleeding risk

Full-Text   Cite this paper   Add to My Lib

Abstract:

American College of Cardiology (ACC) guidelines suggest clopidogrel (Plavix) suspension for 5 days before non-emergent cardiac surgery (class IIa, level B). It puts the patients with recent angioplasty and ongoing ischemia at a higher risk of stent thrombosis. We sought to determine the bleeding risk in patients who stopped clopidogrel at 3 and less than 3 days before coronary artery bypass grafting (CABG) as compared to the usual 5 days prior to CABG

Full-Text

  
  
  

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133